
Choosing Your Blood Cancer Specialist in Zhejiang: Lymphoma, Myeloma, Leukemia & Beyond
Overview
Blood cancers — lymphoma, multiple myeloma, leukemia, and related conditions — are among the most complex and rapidly evolving areas of oncology. Treatment decisions require deep expertise in molecular subtyping, novel agents, CAR-T cell therapy, stem cell transplantation, and increasingly, integrative medicine. Zhejiang is home to some of the world’s most experienced blood cancer specialists across every discipline. This guide, CMS, helps international patients navigate their options based on their specific diagnosis and clinical situation.
Zhejiang’s Leading Blood Cancer Specialists at a Glance
表格
| Specialist | Hospital | Key Focus |
|---|---|---|
| Prof. Tong Hongyan | The First Affiliated Hospital, Zhejiang University School of Medicine | Lymphoma molecular subtyping & precision treatment; Director of Lymphoma Center & MDS Center; Vice Director, Zhejiang Clinical Research Center of Hematology |
| Prof. Yang Haiyan | Zhejiang Cancer Hospital | Lymphoma & myeloma; CAR-T specialist; Director of Lymphoma Department; leading lymphoma precision immunotherapy & auto‑SCT |
| Prof. Huang He | The First Affiliated Hospital, Zhejiang University School of Medicine | Leukemia & hematopoietic stem cell transplantation; Director of Bone Marrow Transplant Center; 973 Chief Scientist, Asia BMT board member |
| Prof. Yu Wenjuan | The First Affiliated Hospital, Zhejiang University School of Medicine | Multiple myeloma & plasma cell disorders; IMWG collaborator; guideline-aligned management for high-risk and relapsed myeloma |
| Prof. Hu Yongxian | The First Affiliated Hospital, Zhejiang University School of Medicine | Myeloma, lymphoma, CAR-T & stem cell transplantation; pioneer of “Hangzhou Protocol” (CAR-T bridging transplant); top-ranked cellular therapy program |
| Prof. Jin Jie | The First Affiliated Hospital, Zhejiang University School of Medicine | Leukemia immunotherapy & elderly blood cancer; senior national hematology expert; precision regimens for frail and older AML/ALL patients |
| Prof. Zhou Yuhong | Zhejiang Provincial Hospital of Chinese Medicine | Integrative TCM-Western medicine for blood disorders; National TCM clinical research base lead for hematology; aplastic anaemia, ITP, leukaemia supportive care |
How to Choose: Matching Your Diagnosis to the Right Specialist
🔵 Lymphoma & CAR-T Cell Therapy For patients with lymphoma — particularly diffuse large B-cell lymphoma (DLBCL), T-cell lymphomas, follicular lymphoma, or relapsed/refractory disease requiring CAR-T therapy:
Prof. Tong Hongyan — Zhejiang’s foremost lymphoma precision medicine specialist and Director of the Lymphoma Center at The First Affiliated Hospital, Zhejiang University. Prof. Tong runs one of China’s strongest programmes for lymphoma molecular classification, double‑hit/triple‑hit lymphoma, peripheral T-cell lymphoma, and high-risk indolent lymphoma. Her deep experience in NGS-based subtyping makes her the first choice for patients with complex or treatment-resistant lymphoma requiring the most precise diagnostic and therapeutic approach.
Prof. Yang Haiyan — Director of Lymphoma Department at Zhejiang Cancer Hospital, a dedicated lymphoma centre focused on relapsed/refractory large B-cell lymphoma and CAR-T delivery. For patients who are CAR-T candidates, Prof. Yang’s team has broad real-world experience in patient selection, toxicity monitoring, post-CAR-T consolidation and autologous stem cell transplantation. Her department also delivers comprehensive myeloma care alongside its lymphoma expertise.
🟡 Multiple Myeloma & Plasma Cell Disorders For patients with multiple myeloma, smoldering myeloma, AL amyloidosis, Waldenström macroglobulinemia, or other plasma cell disorders:
Prof. Yu Wenjuan — One of Zhejiang’s leading myeloma specialists with close alignment to International Myeloma Working Group (IMWG) standards. Prof. Yu contributes to domestic and international myeloma consensus practice and offers authoritative opinions for newly diagnosed high-risk myeloma, early relapse, triple-class refractory myeloma, and rare plasma cell dyscrasias.
Prof. Hu Yongxian — Deputy Director of the Bone Marrow Transplant Center at The First Affiliated Hospital, ZJU, creator of the internationally recognised “Hangzhou Protocol”: CAR-T sequential bridging to allogeneic stem cell transplantation. Prof. Hu’s programme combines novel agent therapy, BCMA CAR-T, and autologous/allogeneic transplantation for myeloma, making it ideal for patients seeking integrated cell therapy and transplant options within one centre.
🔴 Leukemia & Hematopoietic Stem Cell Transplantation For patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), myelodysplastic syndromes (MDS), or those requiring stem cell transplantation:
Prof. Huang He — Director of the Bone Marrow Transplant Center and Zhejiang Institute of Hematology, a globally recognised authority on all forms of hematopoietic stem cell transplantation, including matched sibling, MUD, and haploidentical transplant. Prof. Huang’s decades of work in high-risk leukaemia, MDS and transplant immunology makes him the first choice for patients needing transplant eligibility assessment and curative-intent cell therapy.
Prof. Jin Jie — Senior national expert in leukaemia and blood cancer in older and unfit patients. For elderly AML or ALL patients who cannot tolerate intensive chemotherapy, Prof. Jin’s team specialises in low-intensity venetoclax‑based regimens, FLT3/IDH targeted inhibitors, and antibody‑based immunotherapy including blinatumomab and inotuzumab, expanding effective options for vulnerable populations.
🌿 Integrative TCM-Western Medicine: Supportive Care & Non-Malignant Blood Disorders For patients who wish to incorporate Traditional Chinese Medicine into their blood cancer care, or who have non-malignant blood disorders (aplastic anaemia, ITP, AIHA) where integrative TCM-Western treatment offers disease-modifying benefits:
Prof. Zhou Yuhong — Academic lead of the National TCM Clinical Research Base for Hematology at Zhejiang Provincial Hospital of Chinese Medicine, and a nationally recognised leader in integrative hematology. Prof. Zhou’s programme is especially well-regarded for aplastic anaemia and immune thrombocytopenia (ITP), where TCM herbal therapy has demonstrated disease-modifying effects. It also supports leukaemia and lymphoma patients during chemo‑/immunotherapy to reduce toxicities, accelerate bone marrow recovery, and preserve quality of life.
Important Notes for International Patients
Specialist clinic schedules change frequently. Before travelling to Zhejiang, always confirm the latest appointment availability through the hospital’s official app, website, or by contacting CMS directly.
Bring all prior medical records. For blood cancers, this includes bone marrow biopsy reports, cytogenetics, molecular profiling (NGS), flow cytometry, PET-CT, and a complete treatment history. Complete documentation enables the most accurate assessment and treatment planning.
Remote pre-consultation is available. All specialists featured in this guide can review your records remotely before your arrival in Zhejiang — enabling a preliminary treatment recommendation to be developed before you travel.
A second opinion is always worthwhile. For patients with complex molecular profiles, treatment-resistant disease, or rare subtypes, CMS can arrange consultations with multiple specialists to ensure you have the most comprehensive picture.
How CMS Can Help
CMS acts as your dedicated medical concierge, coordinating every aspect of your blood cancer care across Zhejiang so you can focus on what matters most.
Our services include:
✅ Expert matching — we assess your case and recommend the most appropriate specialist(s) for your situation
✅ Direct appointment coordination with all featured specialists
✅ Bone marrow biopsy, molecular profiling, PET-CT, and treatment record translation and pre-consultation review
✅ CAR-T therapy and clinical trial eligibility assessment
✅ Second opinion facilitation
✅ Hospital admission and treatment scheduling support
✅ Accommodation and logistics coordination in Zhejiang
✅ Post-treatment follow-up and remote check-in support
Leave a reply